In a Danish study, Haase et al. [33] showed that certain rare allelic variants (eg variant A164S) of the APOA1 gene are associated with decreased plasma levels of ApoA-I and HDL-C and predispose to amyloidosis, with an increased risk of CAD and MI [33]. This evidence concerns the gene APOA1 and coronary artery disorder.